Anagliptin Completed Phase 4 Trials for Type 2 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04810507MAGE of Anagliptin Compared With Sitagliptin With Type 2 Diabetes Mellitus